• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早晨不同光色温对缺血性脑卒中患者康复训练效果的影响:一项前瞻性、单中心、随机对照临床试验

Different light color temperatures in the morning on the effectiveness of rehabilitation training in patients with ischemic stroke: a prospective, single-center, randomized controlled clinical trial.

作者信息

Wang Nan, Xue Yan, Wang Tongyue, Qiu Fengxi, Li Cheng, Wang Zhiyuan, Jiang Jianke, Lu Yi, Shao Yingqi, Bai Zhongfei, Lan Danmei, Hu Qilong, Wu Hengjing

机构信息

Department of Traditional Chinese Medicine, Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, 201619, China.

Clinical Research Center, Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, 201619, China.

出版信息

J Neuroeng Rehabil. 2025 Jul 14;22(1):162. doi: 10.1186/s12984-025-01679-9.

DOI:10.1186/s12984-025-01679-9
PMID:40660285
Abstract

BACKGROUND

Stroke is a leading cause of death and disability worldwide, especially in China, where its incidence is rising. Post-stroke rehabilitation is crucial for restoring neurological function and improving quality of life. Light therapy, a non-pharmacological intervention, is gaining attention for its potential to promote neuroplasticity and enhance brain circulation. Warm and cold light, characterized by different color temperatures, have demonstrated beneficial effects on sleep quality, neurological recovery, and emotional well-being in stroke patients. However, the underlying mechanisms remain incompletely understood. This study explores the effects of different light color temperatures on stroke recovery to optimize rehabilitation approaches.

METHODS

The study was designed as a prospective, single-center, randomized controlled trial. 48 patients with ischemic stroke were randomly divided into three groups (1:1:1): warm light group (WLG, 500 lx, 3000 K, n = 16), cold light group (CLG, 500 lx, 6500 K, n = 16), and control group (CG, 500 lx, 5000 K, n = 16). Patients in all three groups received 60 min of rehabilitation therapy daily, from Monday to Friday between 8:30 and 9:30 AM, under light environments with different color temperatures. National Institutes of Health Stroke Scale (NIHSS), Short Form-36 (SF-36), Self-Rating Sleep Scale (SRSS), and levels of interleukin 6 (IL-6), norepinephrine (NE) and melatonin (MT) were measured before and after 4 weeks of intervention.

RESULTS

After 4 weeks intervention, CLG showed a significant reduction of NIHSS when compared to CG(p < 0.001, partial η = 0.316) and WLG(p = 0.003, partial η = 0.237). Although all three groups showed significant reductions in SRSS scores in the within-group comparisons, between-group comparisons revealed that CLG demonstrated a significantly greater reduction in SRSS compared to CG (p = 0.004, partial η = 0.253) and WLG (p = 0.007, partial η = 0.241). Regarding the SF-36, the physical component summary (PCS) score significantly decreased in both CG (Δ = -5.34 ± 7.35, p = 0.011) and WLG (Δ = -3.63 ± 4.68, p = 0.015), while CLG showed a significant improvement (Δ = 4.28 (8.78), p = 0.024). Between-group analysis demonstrated that post-intervention PCS scores were significantly higher in CLG compared to CG (p = 0.001, partial η = 0.323) and WLG (p = 0.002, partial η = 0.326), with no significant difference between CG and WLG (p = 0.104). Mental component summary (MCS) scores showed no statistically significant differences either within or between groups. No significant changes in NE and IL-6 levels were observed across all groups. CLG showed a significant reduction of MT when compared to WLG(p = 0.018, partial η = 0.174). No apparent adverse events were reported.

CONCLUSIONS

This study demonstrated that cold light therapy significantly improves neurological function, sleep quality, physical health status, including better performance on the physical component of quality of life in post-stroke patients, while warm light shows moderate benefits in sleep. These results support the integration of light-based interventions as adjunctive strategies in post-stroke care. Trial registration The study was registered in Chinese Clinical Trial Registry as a clinical trial ID (ChiCTR2200057541), March 14, 2022.

摘要

背景

中风是全球范围内导致死亡和残疾的主要原因,在中国尤其如此,其发病率正在上升。中风后康复对于恢复神经功能和提高生活质量至关重要。光疗法作为一种非药物干预手段,因其促进神经可塑性和增强脑循环的潜力而受到关注。暖光和冷光具有不同的色温,已证明对中风患者的睡眠质量、神经恢复和情绪健康有有益影响。然而,其潜在机制仍未完全了解。本研究探讨不同光色温对中风恢复的影响,以优化康复方法。

方法

本研究设计为一项前瞻性、单中心、随机对照试验。48例缺血性中风患者被随机分为三组(1:1:1):暖光组(WLG,500勒克斯,3000开尔文,n = 16)、冷光组(CLG,500勒克斯,6500开尔文,n = 16)和对照组(CG,500勒克斯,5000开尔文,n = 16)。三组患者均在不同色温的光照环境下,每天上午8:30至9:30接受60分钟的康复治疗,周一至周五进行。在干预4周前后测量美国国立卫生研究院卒中量表(NIHSS)、简明健康调查问卷(SF - 36)、自评睡眠量表(SRSS)以及白细胞介素6(IL - 6)、去甲肾上腺素(NE)和褪黑素(MT)水平。

结果

干预4周后,与CG组相比,CLG组NIHSS显著降低(p < 0.001,偏η = 0.316),与WLG组相比也显著降低(p = 0.003,偏η = 0.237)。虽然三组组内比较SRSS评分均显著降低,但组间比较显示,与CG组相比,CLG组SRSS降低更显著(p = 0.004,偏η = 0.253),与WLG组相比也更显著(p = 0.007,偏η = 0.241)。关于SF - 36,CG组(Δ = -5.34 ± 7.35,p = 0.011)和WLG组(Δ = -3.63 ± 4.68,p = 0.015)的身体成分总结(PCS)评分均显著下降,而CLG组则显著改善(Δ = 4.28(8.78),p = 0.024)。组间分析表明,干预后CLG组的PCS评分显著高于CG组(p = 0.001,偏η = 0.323)和WLG组(p = 0.002,偏η = 0.326),CG组和WLG组之间无显著差异(p = 0.104)。心理成分总结(MCS)评分在组内和组间均无统计学显著差异。所有组的NE和IL - 6水平均未观察到显著变化。与WLG组相比,CLG组MT显著降低(p = 0.018,偏η = 0.174)。未报告明显不良事件。

结论

本研究表明,冷光疗法可显著改善中风患者的神经功能、睡眠质量和身体健康状况,包括在生活质量身体成分方面表现更好,而暖光在睡眠方面显示出适度益处。这些结果支持将基于光的干预作为中风后护理的辅助策略。试验注册 本研究于2022年3月14日在中国临床试验注册中心注册为临床试验ID(ChiCTR2200057541)。

相似文献

1
Different light color temperatures in the morning on the effectiveness of rehabilitation training in patients with ischemic stroke: a prospective, single-center, randomized controlled clinical trial.早晨不同光色温对缺血性脑卒中患者康复训练效果的影响:一项前瞻性、单中心、随机对照临床试验
J Neuroeng Rehabil. 2025 Jul 14;22(1):162. doi: 10.1186/s12984-025-01679-9.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.
5
Yoga for chronic non-specific low back pain.瑜伽治疗慢性非特异性下腰痛。
Cochrane Database Syst Rev. 2022 Nov 18;11(11):CD010671. doi: 10.1002/14651858.CD010671.pub3.
6
Nutritional therapy for reducing disability and improving activities of daily living in people after stroke.脑卒中后通过营养疗法减少残疾和提高日常生活活动能力。
Cochrane Database Syst Rev. 2024 Aug 15;8(8):CD014852. doi: 10.1002/14651858.CD014852.pub2.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
9
Pulmonary rehabilitation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺康复治疗
Cochrane Database Syst Rev. 2015 Feb 23;2015(2):CD003793. doi: 10.1002/14651858.CD003793.pub3.
10
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.

本文引用的文献

1
The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions.白细胞介素-6(IL-6)及间充质干细胞源性IL-6对神经系统疾病的影响。
Front Immunol. 2024 Jun 24;15:1400533. doi: 10.3389/fimmu.2024.1400533. eCollection 2024.
2
Bright Light Therapy as Add-On to Inpatient Treatment in Youth With Moderate to Severe Depression: A Randomized Clinical Trial.光照疗法作为中重度抑郁症住院患者的附加治疗手段:一项随机临床试验。
JAMA Psychiatry. 2024 Jul 1;81(7):655-662. doi: 10.1001/jamapsychiatry.2024.0103.
3
China stroke surveillance report 2021.
中国卒中监测报告 2021。
Mil Med Res. 2023 Jul 19;10(1):33. doi: 10.1186/s40779-023-00463-x.
4
Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation.探究白细胞介素-6 在中风病理学和神经干细胞移植中的作用。
Int J Mol Sci. 2022 Dec 7;23(24):15453. doi: 10.3390/ijms232415453.
5
Melatonin as an Antioxidant Agent in Stroke: An Updated Review.褪黑素作为中风中的一种抗氧化剂:最新综述
Aging Dis. 2022 Dec 1;13(6):1823-1844. doi: 10.14336/AD.2022.0405.
6
Impact of light therapy on rotating night shift workers: the EuRhythDia study.光照疗法对轮班夜间工作者的影响:EuRhythDia 研究。
Acta Diabetol. 2022 Dec;59(12):1589-1596. doi: 10.1007/s00592-022-01956-2. Epub 2022 Aug 31.
7
Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study.白细胞介素-6 和 YKL-40 预测缺血性卒中和 TIA 后的复发性卒中:一项前瞻性队列研究中 6 种炎症生物标志物的分析。
J Neuroinflammation. 2022 Jun 6;19(1):131. doi: 10.1186/s12974-022-02467-1.
8
Acupuncture and Traditional Chinese Herbal Medicine Integrated With Conventional Rehabilitation for Post-stroke Functional Recovery: A Retrospective Cohort Study.针灸和中药联合传统康复治疗对脑卒中后功能恢复的影响:一项回顾性队列研究
Front Neurosci. 2022 Mar 16;16:851333. doi: 10.3389/fnins.2022.851333. eCollection 2022.
9
Interleukins and Ischemic Stroke.白细胞介素与缺血性脑卒中。
Front Immunol. 2022 Jan 31;13:828447. doi: 10.3389/fimmu.2022.828447. eCollection 2022.
10
Estimating the minimal clinically important difference for the Physical Component Summary of the Short Form 36 for patients with stroke.评估脑卒中患者健康调查简表物理成分综合得分的最小临床重要差异。
J Int Med Res. 2021 Dec;49(12):3000605211067902. doi: 10.1177/03000605211067902.